DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA]

ABSTRACT: To investigate transcriptomic changes regulated by DUSP6 in a HER2+ breast cancer cell line We performed gene expression profiling analysis using data obtained from RNA-seq of SCR vs DUSP6 KD MDA-MB-453 cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE231524 | GEO | 2024/04/13

REPOSITORIES: GEO